Yu-fei Xu

发表

HSP70 and modified HPV 16 E7 fusion gene without the addition of a signal peptide gene sequence as a candidate therapeutic tumor vaccine.

J. Zong, Changyuan Wang, Qing-yong Wang, 2013, Oncology reports.

Trivalent Human Papillomavirus (HPV) VLP vaccine covering HPV type 58 can elicit high level of humoral immunity but also induce immune interference among component types.

Xueling Wu, Youchun Wang, L. Qiao, 2010, Vaccine.

Type-specific and cross-reactive antibodies induced by human papillomavirus 31 L1/L2 virus-like particles.

Qing-yong Wang, Yu-fei Xu, Xue-mei Xu, 2007, Journal of medical microbiology.

The role of CD40-CD154 interaction in cell immunoregulation.

Yu-fei Xu, G. Song, Yufei Xu, 2004, Journal of biomedical science.

The Role of CD40-CD154 Interaction in Cell Immunoregulation

Yu-fei Xu, G. Song, Yufei Xu, 2004, Journal of Biomedical Science.

Encapsidating artificial human papillomavirus‐16 mE7 protein in human papillomavirus‐6b L1/L2 virus like particles

Qing-yong Wang, Yu-fei Xu, Xue-mei Xu, 2007, Chinese medical journal.

Enhancement of vaccine potency by fusing modified LTK63 into human papillomavirus type 16 chimeric virus-like particles.

Hongtao Zhang, Yu-fei Xu, Xue-mei Xu, 2008, FEMS immunology and medical microbiology.

Enhancementof vaccinepotencyby fusingmodi ¢ edLTK 63 into human papillomavirus type 16 chimeric virus-likeparticles

Hongtao Zhang, Yu-fei Xu, Xue-mei Xu, 2007 .

Trivalent Human Papillomavirus (HPV) VLP vaccine covering HPV type 58 can elicit high level of humoral immunity but also induce immune interference among component types.

Xueling Wu, Youchun Wang, L. Qiao, 2010, Vaccine.